
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
The 9-year-old boy in the emergency department examining room is significantly hypertensive. He is here because his mother called 911 after she discovered him on the bathroom floor limp, staring, unresponsive, and making a "clucking" noise.






